spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Generic

 HSMN NewsFeed - 2 Jul 2007
Valeant Pharmaceuticals Settles Suit with Kali Laboratories on Diastat Generic Challenge
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Jun 2007
Breckenridge Pharmaceutical, Inc. and Chemo/Liconsa (Spain) Agree to Develop and Market Generic ANDA
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Jun 2007
Teva Announces Approval of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jun 2007
Teva Announces Tentative Approval of Famciclovir Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Effexor(R) Tablets, 25mg, 37.5mg, 50mg, 75mg and 100mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Actavis Launches Generic Adalat(R) CC Tablets in the U.S.
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Jun 2007
KV Pharmaceutical Company Receives ANDA Approval for 4 mg. and 8 mg. Ondansetron Orally Disintegrating Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jun 2007
Barr Receives Approval for Generic VESANOID(R) Capsules, 10 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jun 2007
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Jun 2007
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jun 2007
Bradley Pharmaceuticals Launches Authorized Generic of ADOXA(R)
Biopharmaceuticals Dermatology Generics
 HSMN NewsFeed - 11 Jun 2007
U.S. Department of Justice Investigation of Bristol-Myers Squibb in Proposed Plavix Patent Settlement Is Resolved
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Jun 2007
US Court Allows Teva to Resume US Sales of Its Generic Version of Lotrel
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Jun 2007
Teva Receives Favorable Court Decision Regarding Generic Lotrel(R); Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Jun 2007
Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Jun 2007
Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Jun 2007
Perrigo Wins Famotidine Complete Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Jun 2007
Barr Announces Tentative Approval for a Generic Version of Risperdal(R) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Jun 2007
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Jun 2007
Generic Medical Devices Announces U.S. Sales Force as First Generic Devices Go to Market
Devices Personnel
 HSMN NewsFeed - 1 Jun 2007
IMPAX Announces Decision on Generic Prilosec(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 May 2007
HalcyGen to target US$1b drugs market with licenses
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 31 May 2007
Mylan Announces Final FDA Approval for Azithromycin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2007
Bristol-Myers Squibb Pleads Guilty to Lying to the Federal Government About Deal Involving Blood-Thinning Drug
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 May 2007
Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2007
Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 May 2007
US Court Continues to Prevent Teva From Shipping Any Additional Generic Copies of the High Blood Pressure Medicine Lotrel
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 May 2007
Ranbaxy Successfully Challenges Atorvastatin Patents in Norway
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 29 May 2007
Pfizer Will Immediately Seek to Appeal Lipitor Patent Ruling in Norway
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 29 May 2007
Hi-Tech Pharmacal Settles Litigation with MedPointe and JFC Technologies, Acquires Vosol(R) Product Line
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 21 May 2007
Teva Provides Update on Generic Lotrel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 May 2007
Actavis Launches Finasteride 5 mg Tablets in the U.S.
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 21 May 2007
Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 May 2007
Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol Succinate Extended-Release 50 mg Tablets; Relinquishes 180-Day Market Exclusivity
Biopharmaceuticals Generics
 HSMN NewsFeed - 20 May 2007
Teva Provides Update on Generic Lotrel(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 May 2007
Lupin Receives US FDA Approval for Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 May 2007
Generic Medical Devices Establishes European Headquarters in Brussels
Devices
 HSMN NewsFeed - 13 May 2007
Teva Comments About the Acquisition of Merck KGaA Generic Business
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2007
Mylan Laboratories to Acquire Generics Business of Merck KGaA
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 May 2007
Abraxis BioScience Receives FDA Approvals for Clindamycin Injection, USP
Biopharmaceuticals Generics FDA
Older Generic stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!